Singapur - anglès - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - lamivudine; zidovudine - tablet, film coated - 150 mg - lamivudine 150 mg; zidovudine 300 mg

Singapur - anglès - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - lamivudine - solution - 10 mg/ml - lamivudine 10 mg/ml

Singapur - anglès - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - lamivudine - tablet, film coated - 150 mg - lamivudine 150 mg

Unió Europea - anglès - EMA (European Medicines Agency)

torbet laboratories ireland limited - urea (13c) - breath tests; helicobacter infections - diagnostic agents - this medicinal product is for diagnostic use only.for in vivo diagnosis of gastroduodenal helicobacter pylori (h. pylori) infection.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - amoxicillin sodium 1063 g equivalent to 1000 mg amoxicillin;   - powder for injection - 1 g/10ml - active: amoxicillin sodium 1063 g equivalent to 1000 mg amoxicillin   - fisamox is indicated in the treatment of infections due to susceptible strains of the organisms listed below. gram-negative organisms: haemophilus influenzae escherichia coli proteus mirabilis neisseria gonorrhoea gram-positive organisms: streptococcus species streptococcus penumoniae non-penicillinase-producing staphylococci fisamox powder for injection is intended for use where the patient's condition precludes the administration of the oral form. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however in emergency cases where the causative organism has not yet been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. prophylaxis of endocarditis: fisamox may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with prosthetic heart valves or those who have previously had endocarditis.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - amoxicillin sodium 531.6mg equivalent to 500 mg amoxicillin;   - powder for injection - 500 mg/10ml - active: amoxicillin sodium 531.6mg equivalent to 500 mg amoxicillin   - fisamox is indicated in the treatment of infections due to susceptible strains of the organisms listed below. gram-negative organisms: haemophilus influenzae escherichia coli proteus mirabilis neisseria gonorrhoea gram-positive organisms: streptococcus species streptococcus penumoniae non-penicillinase-producing staphylococci fisamox powder for injection is intended for use where the patient's condition precludes the administration of the oral form. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however in emergency cases where the causative organism has not yet been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. prophylaxis of endocarditis: fisamox may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with prosthetic heart valves or those who have previously had endocarditis.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - flucloxacillin sodium monohydrate 1048mg equivalent to flucloxacillin 1000 mg - powder for injection - 1 g - active: flucloxacillin sodium monohydrate 1048mg equivalent to flucloxacillin 1000 mg - flucil is indicated for the treatment of skin and soft tissue infections caused by susceptible organisms and infections due to penicillinase producing staphylococci and for mixed streptococcal and staphylococcal infections where the staphylococci are resistant to penicillin. for example, infections of the joints, respiratory tract and urinary tract, otitis media, endocarditis, septicaemia, and meningitis. flucil is also used in the prophylaxis of staphylococcal infections during major surgical procedures, particularly in cardiothoracic or orthopaedic surgery.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - flucloxacillin sodium monohydrate 524mg equivalent to flucloxacillin 500 mg - powder for injection - 500 mg - active: flucloxacillin sodium monohydrate 524mg equivalent to flucloxacillin 500 mg - flucil is indicated for the treatment of skin and soft tissue infections caused by susceptible organisms and infections due to penicillinase producing staphylococci and for mixed streptococcal and staphylococcal infections where the staphylococci are resistant to penicillin. for example, infections of the joints, respiratory tract and urinary tract, otitis media, endocarditis, septicaemia, and meningitis. flucil is also used in the prophylaxis of staphylococcal infections during major surgical procedures, particularly in cardiothoracic or orthopaedic surgery.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

in vitro technologies pty ltd - 13732 - sterilization process indicator, biological - a sterilisation indicator consisting of a standardised, viable population of micro-organisms e.g. bacterial spores, known to be resistant to the mode of sterilisation being monitored. used for validation and routine monitoring of the sterilisation process.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - piperacillin,tazobactam -